SynthesisCancer medicine2016

Effects of lapatinib or trastuzumab, alone and in combination, in human epidermal growth factor receptor 2-positive breast cancer: a meta-analysis of randomized controlled trials.

Yong Xin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.